Clinical Trial Update: Cannabis (THC vs. CBD) in Multiple Sclerosis [Phase 2]

View source ↗

Summary

This document provides a Phase 2 trial update comparing THC and CBD for multiple sclerosis. The trial is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cannabis (CBD) (Cannabidiol)
• Cannabis (THC) (Delta-9-tetrahydrocannabinol)

Snippet

Sponsor: University of Calgary | Conditions: Multiple Sclerosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING